ClinicalTrials.Veeva

Menu

Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients (PROSCEED)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Tobacco Cessation

Treatments

Other: STIR PROTOCOL

Study type

Interventional

Funder types

Other

Identifiers

NCT05552534
ID RCB 2021-A03003-38 (Other Identifier)
APHP220066

Details and patient eligibility

About

Smoking cessation assistance is one of the major issues in prevention policies because the prevalence of smoking remains high in France. With its numerous consultations, an emergency service seems to be an interesting place for setting up and helping with weaning, despite specific working conditions. The study, which is a pilot, is interested in the feasibility and efficacy of the implementation of a STIR (Screening, Treatment Intervention and Referral) protocol, which screening, brief intervention, nicotine replacement therapy and referral to a specialist in order to help the patients in smoking cessation.

Full description

Individual randomization as soon as the patient gives his consent and meets the inclusion - non-inclusion criteria.

Control group: delivery of the "tobacco-info-service" brochure titled "Why quit smoking? ", then phone call at 7 days and a month to collect tobacco consumption. Visit for 3 month. Intervention group: STIR protocol (screening, brief intervention, incentive to download the tobacco info service application, delivery of the "tobacco-info-service" brochure, initiation of a nicotine replacement therapy with nicotine patches made by a trained emergency nurse or doctor, then three consultations face-to-face or remotely with a member of the team addictionology at 7 days, 1 and 3 months.

In both groups: collection of the primary endpoint during the M3 visit. For patients who did not come (regardless of the group):

call for collection of the main judgment criterion

Carers will be included and will sign a consent form once the eligibility criteria have been checked and consent has been signed. They will be asked to complete an adherence questionnaire (Likert scale) regarding smoking prevention in emergency departments before the start of the study and after the last patient follow-up has taken place.

Enrollment

152 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >= to 18 years old
  • Active smoker defined by having smoked at least 100 cigarettes in total in his life, associated with daily consumption or weekly
  • Free and informed consent signed by the patient
  • Patient with an understanding of the French language to participate in the intervention if necessary
  • Patient affiliated to a social security regimen

Care giver inclusion criteria:

  • Age ≥ 18 years
  • Caregiver working in one of the 3 departments participating in the study
  • Signature of free and informed consent

Exclusion criteria

  • Absolute vital emergency
  • Pregnant or breastfeeding women
  • Contraindication to taking nicotine
  • Taking nicotine by patch or gum or e-cigarette
  • Patient under AME (national medical insurance)
  • Patients under guardianship

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

152 participants in 2 patient groups

Intervention group
Experimental group
Treatment:
Other: STIR PROTOCOL
Control group
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Judith Leblanc, Nurse degree, PhD.; Anne Laure Philippon, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems